BC Partners acquires a majority stake in premium animal health brand PetLab Co.

• Investment leverages BC Partners’ expertise in the pet sector, building on its successful investments in Chewy, PetSmart, VetPartners and Antelliq.
• PetLab Co. is a premium and fast-growing brand within one of the highest growth pet product categories, driven by increased awareness and education on the benefits of supplements.

BC Partners, a leading international investment firm, today announced that it has agreed to acquire a majority stake in PetLab Co., a rapidly growing independent pet supplement brand headquartered in London. The co-founders will also retain a significant investment in the Company. The terms of the transaction were not disclosed.

Founded in 2018, PetLab Co. is dedicated to enhancing pet health and wellness with supplements crafted from premium, science-backed ingredients. The company has quickly established itself as a premium global brand with a loyal, recurring customer base. PetLab Co.’s product portfolio includes probiotic chews, dental cleaning powders, allergy and immune chews, and joint care chews, among others. These supplements address common pet ailments such as mobility issues, digestive problems, and allergies, promoting overall wellness and vitality.

Similar to the human world, increased awareness and education on the benefits of supplements are driving the growth of health-conscious pet parents. As a result, the pet supplements category is one of the fastest-growing segments in the pet products market. PetLab Co. is well positioned to capitalize on these growth trends, thanks to its unique ability to connect with pet parents through an innovative and engaging social media and online presence.

BC Partners will partner closely with PetLab Co.’s founders to support the company’s next stage of growth, leveraging its extensive experience and proven track record in the pet care industry. With prior investments in companies such as Chewy, PetSmart, VetPartners, and Antelliq, BC Partners brings a wealth of knowledge, strategic insight, and a robust network to this partnership. This collaboration aims to accelerate PetLab Co.'s growth trajectory, driving innovation and expanding its product portfolio and market presence.

Michael Chang, Partner and Co-Head, Healthcare at BC Partners: “Our investment in PetLab Co. underscores BC Partners’ partnership approach, supporting entrepreneurs in high-growth businesses where we bring differentiated sector knowledge and experience. BC Partners has a longstanding track record in the pet care space through our investments in PetSmart/Chewy and added knowledge in pet health and wellness through our experience building Chewy Health and investing in VetPartners and Antelliq. PetLab Co. has distinguished itself as a standout performer in the growing, wellness-focused pet supplement category. We are excited to work with the PetLab Co. team on the next stages of the company's growth, driven by our shared mission of improving the lives of pets.”

Chris Masanto, Co-Founder and Co-CEO, PetLab Co: “As pet owners ourselves, we founded PetLab Co. in 2018 to provide the best wellness products for our own pets and share them with other pet parents. Welcoming BC Partners to the PetLab Co. family brings not only financial support but also invaluable industry expertise and relationships. We are thrilled to partner with a firm that shares our commitment to pet wellness. To the team at PetLab Co, thank you for 6 years of relentless hard work. I couldn’t be more excited taking this next step in our journey with you all and BC Partners who I am confident can help take us to the next level. The future couldn’t be brighter.”

BC Partners was advised by Kirkland & Ellis LLP (legal counsel), JP Morgan (financial advisor) and PwC. PetLab Co. was advised by Bank of America

+++

--ENDS --

Media enquiries

BC Partners Luke Charalambous E: luke.charalambous@BCPartners.com T: +44 7775 180 721

About BC Partners BC Partners is a leading investment firm with circa €40 billion in assets under management across private equity, private debt, and real estate strategies. Established in 1986, BC Partners has played an active role for over three decades in developing the European buy-out market. Today BC Partners integrated transatlantic investment teams work from offices in Europe and North America and are aligned across our four core sectors: TMT, Healthcare, Services & Industrials, and Consumer. Since its foundation, BC Partners has completed over 128 private equity investments in companies with a total enterprise value of over €160 billion and is currently investing its eleventh private equity buyout fund. For further information, please visit https://www.bcpartners.com/

About PetLab Co. PetLab Co. is on a mission to deliver breakthrough pet health. Every day, we are realizing our vision to be the world’s most trusted pet health partner by providing innovative and clinically-tested health solutions, educating and engaging pet parents, and making ourselves available to the pet community. Together, with our team of industry veterans, PhD Nutritionists, Product Experts, Clinical Scientists, and Specialized Veterinarians, we employ an inquisitive and ambitious approach to R&D in the nutraceutical space that is grounded in (1) scientific evidence and testing and (2) creating new-to-science, proprietary active-ingredient blends that directly address the root causes of specific pet health issues. A recent powerful example of PetLab Co.’s commitment to groundbreaking R&D is ProBright® Advanced—a powder supplement that represents significant innovation in canine dental care.